U.S. Senate Meeting On FDA User Fees Scheduled For Yesterday Will Instead Occur This Morning, Delayed After FBI Director Firing; Height Securities Believes Amendments Affecting Drug Pricing To Be Introduced But Unlikely To Pass
Hal Lindon